Patents by Inventor Paul John Rennie

Paul John Rennie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090060878
    Abstract: The present invention comprises an oral composition. More particularly to a method of treating and preventing a respiratory tract infection and providing energy, relieving stress, and mood enhancing benefits to a human comprising: the steps of administering to a human a composition comprising from about 450 IU to about 500,000 IU of cholecalciferol, per dose of the composition.
    Type: Application
    Filed: August 29, 2008
    Publication date: March 5, 2009
    Applicant: The Procter & Gamble Company
    Inventors: Jeffrey Warren Clymer, Paul John Rennie
  • Publication number: 20090060879
    Abstract: The present invention comprises an oral composition. More particularly to a method of treating and preventing a respiratory tract infection and providing energy, relieving stress, and mood enhancing benefits to a human comprising: the steps of administering to a human a composition comprising from about 450 IU to about 500,000 IU of cholecalciferol, per dose of the composition.
    Type: Application
    Filed: August 29, 2008
    Publication date: March 5, 2009
    Applicant: The Procter & Gamble Company
    Inventors: Jeffrey Warren Clymer, Paul John Rennie
  • Publication number: 20040234457
    Abstract: The present invention is directed to methods of preventing and treating Severe Acute Respiratory Syndrome (SARS) by the administration of respiratory tract compositions having low pH values. The respiratory tract compositions have a pH of from about 3.0 to about 5.5, and are preferably administered to areas of the respiratory tract such as the nasal cavity to effectively prevent and treat respiratory tract viral infections, particularly SARS. The respiratory tract compositions comprise an organic acid in combination with a metal compound.
    Type: Application
    Filed: February 2, 2004
    Publication date: November 25, 2004
    Applicant: The Procter & Gamble Company
    Inventors: Paul John Rennie, Shane Michael De La Harpe, Jayant Ekanth Khanolkar, Benoit Maurice Mullet
  • Publication number: 20040033260
    Abstract: The present invention is directed to respiratory tract compositions, particularly nasal compositions, that are highly effective in the prevention and treatment of cold and influenza-like symptoms due to respiratory tract viral infections. These compositions comprise chelated and unchelated zinc ions, wherein the quantity of chelated zinc ions is at least about 50.1%.
    Type: Application
    Filed: June 6, 2003
    Publication date: February 19, 2004
    Applicant: The Procter & Gamble Company
    Inventors: Paul John Rennie, Shane Michael De La Harpe, Jayant Ekanth Khanolkar, Michael Ray McDonald, Richard Matthew Charles Sutton
  • Publication number: 20030104038
    Abstract: The present invention relates to methods and devices for treating cough, in particular in which a person in need of cough treatment is provided with a buccally adherent patch and is instructed to stimulate the patch when feeling a need to cough. The invention works through triggering natural physiological control mechanisms in human cerebral cortex to control the cough reflex.
    Type: Application
    Filed: January 6, 2003
    Publication date: June 5, 2003
    Applicant: The Procter & Gamble Company
    Inventors: John David Hull, Paul John Rennie
  • Patent number: D417731
    Type: Grant
    Filed: April 20, 1998
    Date of Patent: December 14, 1999
    Assignee: The Procter & Gamble Company
    Inventors: Michael Edward Butler, Shane Michael de La Harpe, Paul John Rennie, John Edward Sheppard, Richard John Stevens